- Promotional Labeling and Advertising Considerations for Prescription B fda.gov
- Professor Sarfaraz K. Niazi Files Landmark Citizen Petition Urging the FDA to Modernize Biosimilar Approval Pathways and Transform Global Access to Biological Medicines Yahoo Finance
- Biosimilars News Roundup: Approvals Surge Amid Policy Changes Center for Biosimilars
- FDA’s Drug Price Push in Biosimilar Plan Hinges on Other Reforms Bloomberg Law News
- Is FDA Streamlining Regulations in the Biosimilar Space? Pharmaceutical Executive
